Avid Bioservices Inc (CDMO)

[biopharm]

CNBC Squak Box 1/3/2011 had Myrtle Potter ( former President & Chief Operating Officer of Genentech 2000-20005 ) on the show to discuss todays pharmaceutical companies and the lack of new drugs and no major drugs in the pipeline. Avastin was being taken to market while Myrtle Potter was with Genentech but no mention about the latest FDA moves to take Avastin off the market.

She was asked about whether its time for the government to take more control on this industry and she is clearly against that... stating " Its up to private industry...." and also mentioned back when she was with Genentech that it was via mergers and acquisitions that the pipeline was restored for future success of the major BP's. She also stated " In todays big bio pharmaceutical companies... 65% ... thats 65% of todays sales revenue are coming from molecules that came from outside of their labs... "

thats from acquisitions .. mergers... looking at the industry innovators from small biotechs and picking them up at a premium. Its only a matter of time before ... before we get news that atleast we're in talks with someone.

What would PPHM's stock jump to if they were to disclose they were in talks... if someone approached PPHM?

With Avastin continued rejection by the FDA only gives more strength here for PPHM.... its only a matter of time folks... one day we will be waking up to news that will be the beginning of a few millionaires with some investors of Peregrine